EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, WVE: Wave Life Sci Ord Sh

07 Jan 26 15:51
LAST:

15.52

CHANGE:
 0.39		OPEN:
15.40		HIGH:
16.31		ASK:
36.00		VOLUME:
3.8M
CHG(%):
2.54		PREV:
15.13		LOW:
14.79		BID:
20.15		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
07 Jan 2615.4016.3114.7915.523.8M
06 Jan 2619.0519.5015.1215.1515.04M
05 Jan 2615.7416.0014.4615.004.95M
02 Jan 2617.0217.0315.5215.952.87M
31 Dec 2517.2217.3116.9217.001.7M
30 Dec 2517.6917.8617.0217.151.74M
29 Dec 2517.6618.0517.4217.862.17M
26 Dec 2518.2218.3917.6717.771.63M
24 Dec 2517.4918.5017.4918.251.86M
23 Dec 2517.5718.2217.0717.482.8M

PROFILE

Name:Wave Life Sci Ord Sh
About:Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform. The company's RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. It is developing WVE-006, an RNA editing oligonucleotide for the treatment of alpha-1 antitrypsin deficiency; WVE-007, a GalNAc-conjugated small interfering RNA designed to silence INHBE mRNA targeting obesity; WVE-N531, an exon skipping oligonucleotide for the treatment of Duchenne muscular dystrophy; and WVE-003, an allele-selective oligonucleotide for the treatment of Huntington's disease (HD). The company has collaboration agreements with GlaxoSmithKline for the research, development, and commercialization of oligonucleotide therapeutics; Takeda Pharmaceutical Company Limited for the research, development, and commercialization of oligonucleotide therapeutics for disorders of the Central Nervous System; and Asuragen, Inc. for the development and potential commercialization of companion diagnostics for investigational allele-selective therapeutic programs targeting HD. Wave Life Sciences Ltd. was incorporated in 2012 and is based in Singapore.
Sector:Healthcare
Industry:Biotechnology
Address:Marina One East Tower, Singapore, Singapore, 018936
Website:https://wavelifesciences.com
CUSIP:Y95308105
CIK:0001631574
ISIN:USY953081053
FIGI:BBG00B642V54

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-11.87 
Forward P/E:-9.22 
PEG Ratio:-0.49 
Price to Sales:15.32 
Price to Book:10.10 
Profit Margin:-1.38 
Operating Margin:-6.07 
Return on Assets:-0.39 
Return on Equity:-1.71 
EPS Ratio:-0.80 
Revenue:93.95M 
Shares:159.23M 
Market Cap:2.47B 

TECHNICAL INDICATORS

MA5:15.731.4%
MA10:16.727.8%
MA20:17.029.7%
MA50:11.5434.5%
MA100:9.7359.4%
MA200:8.4483.9%
STO9:12.73 
STO14:12.73 
RSI14:45.12
WPR14:-82.37 
MTM14:-0.77
ROC14:-0.05 
ATR:1.42 
Week High:19.5025.7%
Week Low:14.467.3%
Month High:21.7340.1%
Month Low:12.7283.9%
Year High:21.7340.1%
Year Low:5.28193.8%
Volatility:67.76